BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 18398787)

  • 1. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
    Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
    Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW; Hurley JS; Roblin D; Roberts M; Davis KJ; Schreiner R; Frost FJ
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA; Bettoncelli G; Testi R; Viegi G
    Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids in COPD: a controversy.
    Barnes PJ
    Respiration; 2010; 80(2):89-95. PubMed ID: 20501985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA; Fabbri LM; Davis KJ; Soriano JB
    Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Selroos O
    Curr Med Res Opin; 2004 Oct; 20(10):1579-93. PubMed ID: 15462691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.